Literature DB >> 26346844

Gastrointestinal cancer: Tracking tumour evolution through liquid biopsy.

Samra Turajlic1, Charles Swanton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26346844     DOI： 10.1038/nrclinonc.2015.153

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  14 in total

1.  Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.

Authors:  Sandra Misale; Rona Yaeger; Sebastijan Hobor; Elisa Scala; Manickam Janakiraman; David Liska; Emanuele Valtorta; Roberta Schiavo; Michela Buscarino; Giulia Siravegna; Katia Bencardino; Andrea Cercek; Chin-Tung Chen; Silvio Veronese; Carlo Zanon; Andrea Sartore-Bianchi; Marcello Gambacorta; Margherita Gallicchio; Efsevia Vakiani; Valentina Boscaro; Enzo Medico; Martin Weiser; Salvatore Siena; Federica Di Nicolantonio; David Solit; Alberto Bardelli
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

2.  The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies.

Authors:  Claudia Esposito; Anna Maria Rachiglio; Maria Libera La Porta; Alessandra Sacco; Cristin Roma; Alessia Iannaccone; Fabiana Tatangelo; Laura Forgione; Raffaella Pasquale; Americo Barbaro; Gerardo Botti; Fortunato Ciardiello; Nicola Normanno
Journal:  Cancer Biol Ther       Date:  2013-09-23       Impact factor: 4.742

3.  Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.

Authors:  M P Morelli; M J Overman; A Dasari; S M A Kazmi; T Mazard; E Vilar; V K Morris; M S Lee; D Herron; C Eng; J Morris; B K Kee; F Janku; F L Deaton; C Garrett; D Maru; F Diehl; P Angenendt; S Kopetz
Journal:  Ann Oncol       Date:  2015-01-26       Impact factor: 32.976

4.  Detection and quantification of mutations in the plasma of patients with colorectal tumors.

Authors:  Frank Diehl; Meng Li; Devin Dressman; Yiping He; Dong Shen; Steve Szabo; Luis A Diaz; Steven N Goodman; Kerstin A David; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

Review 5.  Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution.

Authors:  Sandra Misale; Federica Di Nicolantonio; Andrea Sartore-Bianchi; Salvatore Siena; Alberto Bardelli
Journal:  Cancer Discov       Date:  2014-10-07       Impact factor: 39.397

6.  Circulating mutant DNA to assess tumor dynamics.

Authors:  Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Nat Med       Date:  2007-07-31       Impact factor: 53.440

7.  Adaptive therapy.

Authors:  Robert A Gatenby; Ariosto S Silva; Robert J Gillies; B Roy Frieden
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

Review 8.  Inferring mutational timing and reconstructing tumour evolutionary histories.

Authors:  Samra Turajlic; Nicholas McGranahan; Charles Swanton
Journal:  Biochim Biophys Acta       Date:  2015-03-27

9.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.

Authors:  Marco Gerlinger; Stuart Horswell; James Larkin; Andrew J Rowan; Max P Salm; Ignacio Varela; Rosalie Fisher; Nicholas McGranahan; Nicholas Matthews; Claudio R Santos; Pierre Martinez; Benjamin Phillimore; Sharmin Begum; Adam Rabinowitz; Bradley Spencer-Dene; Sakshi Gulati; Paul A Bates; Gordon Stamp; Lisa Pickering; Martin Gore; David L Nicol; Steven Hazell; P Andrew Futreal; Aengus Stewart; Charles Swanton
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

10.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962
View more
  2 in total

1.  Current challenges in metastasis research and future innovation for clinical translation.

Authors:  Amelia L Parker; Madeleine Benguigui; Jaime Fornetti; Erica Goddard; Serena Lucotti; Jacob Insua-Rodríguez; Adrian P Wiegmans
Journal:  Clin Exp Metastasis       Date:  2022-01-24       Impact factor: 5.150

Review 2.  Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease.

Authors:  Davide Corti; Jeffrey D Kearns
Journal:  Curr Opin Immunol       Date:  2016-03-23       Impact factor: 7.486
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.